ROIV - Roivant Sciences Ltd
IEX Last Trade
12.23
0.210 1.717%
Share volume: 4,975,512
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.02
0.21
1.75%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-02-13 | 2023-06-28 | 2023-08-14 | 2023-11-13 | 2024-02-13 | 2024-05-30 | |
| Assets | |||||||||
| Total Assets | 2.600 B | 2.216 B | 2.203 B | 2.390 B | 2.137 B | 2.066 B | 7.313 B | 7.222 B | |
| Current Assets | 2.039 B | 1.715 B | 1.646 B | 1.799 B | 1.561 B | 1.552 B | 6.807 B | 6.732 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.240 M | 35.251 M | |
| Other Current Assets | 93.274 M | 111.847 M | 118.795 M | 121.774 M | 127.065 M | 143.396 M | 62.330 M | 72.691 M | |
| Short Term Investments | 93.274 M | 111.847 M | 118.795 M | 121.774 M | 127.065 M | 143.396 M | 62.330 M | 72.691 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 63.188 M | 82.813 M | |
| Current Cash | 1.942 B | 1.599 B | 1.527 B | 1.677 B | 1.434 B | 1.408 B | 6.671 B | 6.536 B | |
| Total Non-current Assets | 560.956 M | 500.673 M | 556.728 M | 591.017 M | 575.488 M | 513.916 M | 505.946 M | 490.654 M | |
| Property Plant Equipment | 31.689 M | 39.171 M | 37.295 M | 39.086 M | 36.270 M | 24.477 M | 21.857 M | 19.058 M | |
| Other Assets | 72.249 M | 64.963 M | 100.859 M | 102.733 M | 97.938 M | 98.425 M | 46.849 M | 39.109 M | |
| Intangible Assets | 145.430 M | 140.298 M | 146.105 M | 144.881 M | 145.037 M | 140.621 M | 150.415 M | 137.842 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.600 B | 2.216 B | 2.203 B | 2.390 B | 2.137 B | 2.066 B | 7.313 B | 7.222 B | |
| Total liabilities | 1.216 B | 1.055 B | 1.247 B | 1.232 B | 1.226 B | 1.117 B | 1.223 B | 1.254 B | |
| Total current liabilities | 328.915 M | 230.744 M | 244.255 M | 272.448 M | 245.004 M | 265.546 M | 244.899 M | 266.758 M | |
| Accounts Payable | 161.304 M | 41.358 M | 47.999 M | 37.830 M | 50.035 M | 44.123 M | 35.226 M | 53.225 M | |
| Other liabilities | 49.486 M | 40.491 M | 101.518 M | 80.578 M | 120.622 M | 36.289 M | 32.802 M | 29.339 M | |
| Current long term debt | 45.162 M | 47.149 M | 49.587 M | 52.413 M | 55.754 M | 59.901 M | 45.706 M | 12.000 M | |
| Long term debt | 444.115 M | 430.150 M | 430.049 M | 428.991 M | 436.881 M | 438.075 M | 403.337 M | 430.591 M | |
| Other liabilities | 49.486 M | 40.491 M | 101.518 M | 80.578 M | 120.622 M | 36.289 M | 32.802 M | 29.339 M | |
| Minority interest | 393.771 M | 353.548 M | 471.618 M | 449.821 M | 423.409 M | 377.099 M | 494.819 M | 479.948 M | |
| Total Shareholder equity | 1.384 B | 1.161 B | 955.520 M | 1.158 B | 910.730 M | 948.534 M | 6.090 B | 5.969 B | |
| Common stock | 695.879 M | 699.888 M | 713.319 M | 742.078 M | 759.274 M | 770.228 M | 800.588 M | 802.907 M | |
| Retained earnings | -3.096 B | -3.387 B | -3.739 B | -3.773 B | -4.065 B | -4.369 B | 727.287 M | 576.172 M |